University of Utah John A. Moran Center

Salt Lake City, Utah 84312

1 studies enrolling now · 3 studies all time

What they study most

Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, Macular Telangiectasia Type 2 (MacTel)

Studies at this site

• Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants — Recruiting now
• An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD — Completed
• A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration — Completed